UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
Positive Breakout: These 7 midcap stocks cross above their 200 DMAs
In the NSE Midcap pack, seven stocks’ close prices crossed above their 200 DMA (Daily Moving Averages) on June 9, according to stockedge.com’s technical scan